Antipsychotic-induced weight gain is an important issue in the treatment of psychotic
illnesses, and affects 80% of individuals being treated with antipsychotic drugs. However …

BACKGROUND: Various antipsychotics are associated with body weight gain. However,
most study samples include high proportions of patients with chronic schizophrenia. We …

With the availability of the so-called novel antipsychotic agents, extrapyramidal symptoms
are becoming decreasingly problematic for patients with schizophrenia, and simultaneously …

Weight gain has been observed with many of the antipsychotics, including the atypical
antipsychotics. The assessment of whether, and to what degree, a drug causes changes in …

BACKGROUND: There is little information about weight gain induced by antipsychotics at
long-term. OBJECTIVE: To quantify the weight gain induced by first (haloperidol) and …

Background Weight gain is among the most important side-effects of antipsychotics. It is,
however, unclear whether it is associated with antipsychotic doses. We aimed to fill this gap …

BACKGROUND: Available data on atypical antipsychotic-induced weight gain are limited by
a number of methodological factors. The objective of this report is to evaluate short-term (N …

Background: Antipsychotic-induced weight gain is one of the most distressing adverse
effects being observed in recent times. Most studies have been limited by several …

Aim: The first-episode psychosis (FEP) represents a critical period to prevent cardiovascular
and metabolic morbidity decades later. Antipsychotic (AP)-induced weight gain is one …

Despite variations across individuals and agents, antipsychotics are associated with clearly
documented weight gain and adverse metabolic effects. Although increased appetite/caloric …